3D/L Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

3D/L Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,722	Closed	-$226K	–	112
2022 Q4	$226K	Sell	1,722 -192	-10%	-$24.8K	0.06%	94
2022 Q3	$224K	Sell	1,914 -25	-1%	-$3.1K	0.07%	86
2022 Q2	$228K	Sell	1,939 -221	-10%	-$26.2K	0.06%	91
2022 Q1	$282K	Buy	2,160 +138	+7%	+$18K	0.07%	100
2021 Q4	$309K	Buy	2,022 +68	+3%	+$10.5K	0.07%	98
2021 Q3	$316K	Sell	1,954 -3	-0.2%	-$505	0.08%	95
2021 Q2	$320K	Buy	1,957 +59	+3%	+$9.09K	0.08%	98
2021 Q1	$286K	Buy	+1,898	New	+$301K	0.07%	100

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

3D/L Capital Management's IBB Position: Q1 2023 in Review

3D/L Capital Management sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 1,722 shares — an estimated $226K sold.

3D/L Capital Management first reported a position in IBB in Q1 2021 and held it in 8 quarters. The position peaked at $320K in Q2 2021. 866 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

3D/L Capital Management reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
3D/L Capital Management sold 1,722 iShares Biotechnology ETF shares in Q1 2023, an estimated $226K.
3D/L Capital Management first reported a position in iShares Biotechnology ETF in Q1 2021 and held it in 8 quarters.
3D/L Capital Management's iShares Biotechnology ETF position peaked at $320K in Q2 2021.
866 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on 3D/L Capital Management's 13F filing for Q1 2023, filed 8 May 2023.